Advertisement
Advertisement
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Bio-Path Holdings Faces Leadership Changes and Operational Pause
Premium
Company Announcements
Bio-Path Holdings Faces Leadership Changes and Operational Pause
5M ago
Bio-Path price target lowered to $2 from $9 at Roth Capital
Premium
The Fly
Bio-Path price target lowered to $2 from $9 at Roth Capital
5M ago
Bio-Path Holdings Reports 2024 Financial Results and Progress
PremiumCompany AnnouncementsBio-Path Holdings Reports 2024 Financial Results and Progress
8M ago
Bio-Path reports FY24 EPS ($4.12) vs ($33.63) last year
Premium
The Fly
Bio-Path reports FY24 EPS ($4.12) vs ($33.63) last year
8M ago
Bio-Path Holdings Reports Promising Pre-Clinical Results
Premium
Company Announcements
Bio-Path Holdings Reports Promising Pre-Clinical Results
8M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
9M ago
Bio-Path receives new patents for P-ethoxy nucleic acids
Premium
The Fly
Bio-Path receives new patents for P-ethoxy nucleic acids
9M ago
Bio-Path provides key clinical updates on BP1001-A, AML
Premium
The Fly
Bio-Path provides key clinical updates on BP1001-A, AML
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100